SOURCE: Medical Marijuana Inc

March 02, 2010 07:20 ET

Medical Marijuana Inc Announces Card Processing OTCBB Company to Joint Venture on Patent Pending Tax Remittance Card; Educational Symposium at San Diego Convention Center; Over 175 Requests for Educational Center Licensing Agreements

LOS ANGELES, CA--(Marketwire - March 2, 2010) -  Medical Marijuana Inc (PINKSHEETS: MJNA) is pleased to announce the upcoming San Diego Educational Symposium at the San Diego Convention Center on March 27th with tickets available at: Strong demand continues for our new Educational Symposiums & Centers and Card Processing Joint Venture Partner for the Company's patent pending tax remittance card.

Kyle Gotshalk -- CEO of CMIB stated: "I am looking forward to our online meeting tomorrow at 11:00 PST. I think the opportunities for a joint venture between Cannabis Medical Solutions, Inc. 'CMIB' and Medical Marijuana Inc 'MJNA' for the future are exciting and we hope we can conclude a contractual agreement this week."

Bruce Perlowin -- CEO of Medical Marijuana Inc said, "This newly created Symposium licensing business opportunity, for the medical marijuana industry, has created a coast to coast sensation of entrepreneurs wanting to enter this area of the industry, as evidenced by the rapid expansion of seminars now scheduled in San Diego, Los Angeles, Rhode Island, and Las Vegas with two new locations coming to Ann Arbor and Grand Rapids, Michigan. This also signals a new and profitable division of MJNA as other inquiries are still pouring in with over 175 requests for licensing agreements in the first 40 days of launching this program. We are also excited about the potential for our patent pending, tax remittance card being quickly launched through a subcontract, joint venture, revenue sharing agreement with the OTCBB Company CMIB. I also expect to be able to announce exciting advancements in our scientific research and development division within the coming weeks."

Martin "Bucky" Fisher -- Newly appointed National Sales Director for Medical Marijuana Inc's Symposium and Learning Center Licensing Division said, "The revenue generated by this newly launched division of our company is significant with MJNA earning revenue from the licensing agreements themselves, the sales of tickets once a local licensee picks their venue, sales of products and services during the events and sales of course material after the events. With 50 requests in just the last 10 days I've had to expand our sales team just to keep up with all the potential licensees coming in."

Medical Marijuana Inc's Educational Symposiums are a multifaceted approach designed to educate anyone interested in entering this emerging multibillion dollar industry. MJNA also offers a complete menu of services including Turnkey Management Solutions and products and services that can be resold through city, regional and state partners who team up with us to hold these Educational Symposiums throughout the country.

Medical Marijuana Inc's Educational Symposiums provide education on topics that include the history of cannabis, cutting edge cultivation, current laws and ordinances, tax compliance, therapeutic uses, caregiver requirements, establishing dispensaries/collectives, and a vast array of business protocols. One can sign up for our upcoming Educational Symposiums via our web site:

For those interested in entering into a Medical Marijuana Inc licensing agreement, please contact us at:, or come to one of our upcoming events to see how they are run and the incredible energy and amazing speakers we feature at these events.


Medical Marijuana Inc has developed a suite of solutions to deliver an efficient and secure infrastructure for the Medical Marijuana Industry which provides the tools to industry operators to effectively manage their business with the confidence that they are in full compliance.


MJNA's Stored Value Platform System provides verifiable solutions to manage the difficult task of revenue and taxation collection. The customers of the dispensary are issued a plastic debit card or medical revenue card. The ease of access to certifiably secure transactions lessens the risk of loss at each level of the transaction.


MJNA acquired 20 acres of land in the mountains of Southern California in order to develop a research facility targeting medical cannabis strains specific to a wide range of medical conditions. By diligently developing the most efficacious strains and matching those strains to ailments, such as glaucoma, MJNA is poised as the industry leader in medical cannabis genetic research.


Medical Marijuana Inc recognizes the vast and unequaled opportunities that exist in the rapidly expanding medical marijuana industry. The scientific recognition of cannabis has brought legalized marijuana use to the forefront of mainstream discussion, thus opening the door for safe and lucrative investment opportunities.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana Inc to be materially different from the statements made herein.